Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2022 · 10-Q
Revenue$5.20M$5.20M+52.4% vs Q2 2021 Net Income-$4.30M-$4.30MN/M vs Q2 2021 EPS Diluted-$0.18-$0.18N/M vs Q2 2021 Gross Profit$3,255,000+43.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$4,981,000N/M Free Cash Flowderived-$5,057,000N/M Margins · derivedGross margin62.6%−4.0 pt vs Q2 2021
Operating margin-80.8%+19.0 pt vs Q2 2021
Net margin-82.8%+26.9 pt vs Q2 2021
ended Jun 30, 2022 · filed Aug 10, 2022 · 41 d after period end